Drug Guide

Generic Name

Glycine

Brand Names Glycine 1.5% In Plastic Container

Classification

Therapeutic: Nutritional supplement, Adjunct in certain medical conditions

Pharmacological: Amino acid, Neurotransmitter

FDA Approved Indications

Mechanism of Action

Glycine acts as an inhibitory neurotransmitter in the central nervous system by binding to glycine receptors, leading to chloride influx and neuronal hyperpolarization; it also functions in the synthesis of proteins, nucleic acids, and other biomolecules.

Dosage and Administration

Adult: Typically used as a supplement or in clinical trials; dosage varies based on specific indications.

Pediatric: Use is off-label; consult healthcare provider.

Geriatric: Adjust based on renal and hepatic function, monitoring for adverse effects.

Renal Impairment: Monitor closely; dosage adjustments may be necessary due to altered metabolism.

Hepatic Impairment: Use with caution; no specific guidelines, but hepatic metabolism may influence dosing.

Pharmacokinetics

Absorption: Well absorbed from gastrointestinal tract when administered orally.

Distribution: Widely distributed in tissues; crosses blood-brain barrier.

Metabolism: Metabolized in the liver via various pathways including glycine cleavage system.

Excretion: Excreted primarily via the kidneys.

Half Life: Approximately 3 hours in plasma.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

Drug-Herb Interactions

Nursing Implications

Assessment: Monitor neurological status, hydration, and renal function.

Diagnoses:

  • Imbalanced nutrition: less than body requirements (if used as supplement)
  • Risk for electrolyte imbalance

Implementation: Administer as prescribed; monitor for adverse effects.

Evaluation: Assess patient response and tolerability; monitor laboratory parameters as indicated.

Patient/Family Teaching

Special Considerations

Black Box Warnings: N/A

Genetic Factors: None specific.

Lab Test Interference: No significant interference reported.

Overdose Management

Signs/Symptoms: Potential CNS depression, hypotension, dysglycemia, or allergic reactions.

Treatment: Supportive care; symptomatic treatment; monitor vital signs; activate emergency services if severe symptoms occur.

Storage and Handling

Storage: Store at room temperature away from light and moisture.

Stability: Stable under recommended storage conditions; consult manufacturer for shelf life.

This guide is for educational purposes only and is not intended for clinical use.